Latest Commercialisation News

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

ALCORE, ABx Group’s subsidiary, has secured government approval for overseas R&D activities and is pursuing a $5 million grant to accelerate its clean fluorine chemical technology commercialisation.

Kinetiko Energy has secured a crucial two-year renewal of its South African exploration rights, advancing its pilot production and development plans amid promising drilling results.

TMK Energy’s LF-07 pilot well at the Gurvantes XXXV Coal Seam Gas Project is producing over 100 cubic metres of gas daily, driving a doubling of total pilot well output since recent drilling. This milestone sets the stage for further production increases as reservoir management advances.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Calix Limited has inked a pivotal MOU and testing agreement with a leading aluminium company to advance its electric calcination technology, aiming to revolutionize alumina production with near-zero emissions.

Firebird Metals has secured a strategic partnership with Kazakhstan-based Taza Metal Technologies to co-fund the development of next-generation manganese-rich battery cathodes, reinforcing its position in the evolving EV materials market.

ABx Group’s latest ANSTO leach tests confirm over 70% extraction of critical heavy rare earths dysprosium and terbium from its Deep Leads project, reinforcing its path to producing a mixed rare earth carbonate sample by year-end.

Astute Metals reports a significant lithium-in-soil anomaly at its Red Mountain Extension project in Nevada, with soil grades up to 1,080ppm and rock chip samples confirming bedrock mineralisation up to 2,690ppm. The company is streamlining its Nevada claims to focus capital on this promising discovery.

Brazilian Rare Earths Limited has obtained the final regulatory approval to operate its rare earth pilot plant in Brazil’s largest petrochemical complex, setting the stage for pilot operations in mid-2026.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.